| 1 |
29456739 | Effects of PHA-665752 and vemurafenib combination treatment on in vitro and murine xenograft growth of human colorectal cancer cells with BRAFV600E mutations. | 2018 Mar |
1 |
| 2 |
27880942 | Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation. | 2017 Jan 3 |
1 |
| 3 |
26456083 | c-Met-mediated reactivation of PI3K/AKT signaling contributes to insensitivity of BRAF(V600E) mutant thyroid cancer to BRAF inhibition. | 2016 Nov |
1 |
| 4 |
27458138 | Hypoxia-Driven Mechanism of Vemurafenib Resistance in Melanoma. | 2016 Oct |
1 |